Aktiesnakken — Maj 2011
-
-
?
-
Nå ser den lige. Jeg ved ikke hvad der sker for dem. Men der er ro på broen
-
Ja det kan jeg godt forstå du siger.
-
Så hæver Nordea atter Satair http://npinvestor.dk/nyheder/nordea-markets-haever-kursmaalet-paa-satair-225025.aspx
-
-
Genmab fastholder sine resultatforventninger til 2011 som offentliggjort den 28.
februar 2011. -
forskning / admin ser godt ud
-
Arzerra lanceret i Tjekkiet.
-
zalutumumab investeringen
“Named patient” program
iværksat !! -
zalu
To studier konverteret til
”named patient”
undersøgelser -
det må nogen analytikere nok lige dyrke på q&a imorgen
-
fuld refusion i frankrig måske
-
på named patient
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind